The Benign
Essential Blepharospasm Research Foundation
MAY 2,
2009
11:30 –
5:00 pm
Meltzer
Auditorium at the Massachusetts Eye and Ear Infirmary
Organized by Gary Borodic, MD in conjunction with
Membership of the Blepharospasm and Meige Disease Research Foundation
Preliminary Conference
Schedule
11:30 – 12:30 Registration
and Reception
Held in the cafeteria - 7th
floor
12:30 – 12:45 Introduction
Gary
Borodic, MD, Senior Surgeon Mass Eye and Ear Infirmary, Moderator
Mary
Lou Thompson, (Koster) Foundation President
Alan
Phair, Regional Organizer
12:45 - 1:25 Basics of Botulinum Toxin Therapeutics
Gary Borodic, MD,
Senior Surgeon Mass Eye and Ear Infirmary and Harvard Medical School
1.
The mechanism of
action
2.
Basic
pharmacology
3.
The original drug
design with subsequent modifications and history
4.
Newer
improvements and overviews
5.
Issues in long
term management
6.
Newer designs and
expanding horizons
Questions and
Answers
1:25 – 2:05 Genetic Research Topics
Clinical Neurologic Approaches
Nutan Sharma, MD,
Director of the Movement Disorders Clinic, Massachusetts General Hospital
1.
Animal models of
DYT1 dystonia
2.
Analysis of the
neurotransmitter defects in animals with the DYT1 mutation
3.
Clinical
evaluation of individuals with dystonia in order to understand how genes affect
dystonia
4.
Medical Therapy
for dystonias with emphasis on head and neck dystonias
5.
Comment on deep
brain stimulation
Questions and
Answers
2:05 –2:45 Clinical Evaluation and
Management
Thomas Hedges, MD
Director of Neuro-Ophthalmology, Tufts Medical Center
1.
Diagnosis of
various blepharospasm syndromes
2.
Extended
experience with botulinum toxin injections
3.
Research with
newer versions of botulinum toxin
4.
Future directions
in management
Questions and
Answers
2:45 – 3:15 Doctor Panel Questions and Answers
COFFEE AND REFRESHMENTS
3:45 – 4:25 Surgical Management of
Essential Blepharospasm and Meige Syndrome
Gary Borodic, MD,
Senior Surgeon Mass Eye and Ear Infirmary and Harvard Medical School
1.
Review of past
procedures
2.
Design,
implementation and preliminary results using small incision myo–osseous
fixation surgery (MOF procedure)
3.
Case analysis of
MOF procedure with 6- 12 month follow-up and safety report
Question and
Answers
4:25 – 4:50 Patient Panel Questions and Answers
4:50 – 5:00 Final Questions and Answers & Closing
Remarks